http://www.ft.com/companies/pharmaceuticalshttp://www.ft.com/rss/companies/pharmaceuticalsFT.com - Pharmaceuticalsen© Copyright The Financial Times Ltd 2009. "FT" and "Financial Times" are trademarks of the Financial Times. See http://www.ft.com/servicestools/help/terms#legal1 for the terms and conditions of reuse.client.support@ft.com (Client Support)Mon, 9 Nov 2009 23:21:20 +0000Tue, 10 Nov 2009 06:08:17 +0000Newspapers15http://news.ft.com/cms/d1f3ce1a-6bbe-11da-bb53-0000779e2340.gifhttp://www.ft.com/companies/pharmaceuticals(PICS-1.1 "http://www.classify.org/safesurf/" L gen true for "http://www.ft.com/" r (SS~~000 1))http://traxfer.ft.com/cms/s/0/f79f8b28-cd4d-11de-8162-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/f79f8b28-cd4d-11de-8162-00144feabdc0.htmlSimultaneous vaccination against seasonal and pandemic flu provides protection against the virus without provoking significant side effects, according to a clinical study released by GlaxoSmithKlineMon, 9 Nov 2009 23:10:21 +0000http://traxfer.ft.com/cms/s/0/8160413a-cd7c-11de-8162-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/8160413a-cd7c-11de-8162-00144feabdc0.htmlThe venture capital model has hampered efforts to create a thriving stem cell sector in the UK and wasted the chance to steal a march on the US, says Jonathan Guthrie Mon, 9 Nov 2009 23:21:20 +0000http://traxfer.ft.com/cms/s/0/ae01c6a6-c9f2-11de-a5b5-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/ae01c6a6-c9f2-11de-a5b5-00144feabdc0.htmlA full half-year of contributions from Protherics boost revenues at the biotechnology group as it looks forward to the direct marketing of two major drugs in the US next yearFri, 6 Nov 2009 05:14:54 +0000http://traxfer.ft.com/cms/s/0/eaf6cd58-ca39-11de-a3a3-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/eaf6cd58-ca39-11de-a3a3-00144feabdc0.htmlSouth Korean prosecutors suspect that they Swiss drugs group illegally provided swine flu treatment to staff of HSBC and Novartis amid fears of a widespread outbreak Thu, 5 Nov 2009 18:49:41 +0000http://traxfer.ft.com/cms/s/0/1481e298-c977-11de-a071-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/1481e298-c977-11de-a071-00144feabdc0.htmlWith a smaller slice of a shrinking domestic pie, Japanese pharmaceutical companies have had to take the fight abroad. The country's track record outside manufacturing does not bode well, but it is too soon to dismiss the industry, writes David Pilling Wed, 4 Nov 2009 20:04:13 +0000http://traxfer.ft.com/cms/s/0/d4af5df8-c8ae-11de-8f9d-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/d4af5df8-c8ae-11de-8f9d-00144feabdc0.htmlThe head of the pioneering tie-up between GlaxoSmithKline and Pfizer predicts the company can operate for at least five years without new funding from shareholdersTue, 3 Nov 2009 22:52:55 +0000http://traxfer.ft.com/cms/s/0/d3edd97a-c88c-11de-a69e-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/d3edd97a-c88c-11de-a69e-00144feabdc0.htmlJohnson & Johnson will cut up to 7% of its 117,000 employees by 2011 as it reduces costs in an effort to weather the global downturn and increase spending on new products.Tue, 3 Nov 2009 21:39:51 +0000http://traxfer.ft.com/cms/s/0/c57f87a4-c8a9-11de-8f9d-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/c57f87a4-c8a9-11de-8f9d-00144feabdc0.htmlNovartis plans to inject $1bn into growing its Shanghai laboratories, which would employ 1,000 scientists, and tap China's scientific baseTue, 3 Nov 2009 19:05:00 +0000http://traxfer.ft.com/cms/s/3/5f8dfe84-c792-11de-8ba8-00144feab49a.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/3/5f8dfe84-c792-11de-8ba8-00144feab49a.htmlA commitment to spend hundreds of millions of dollars on developing obesity drugs is the latest move by a Japanese drugmaker to shore up growth by expanding abroadMon, 2 Nov 2009 23:02:39 +0000http://traxfer.ft.com/cms/s/0/a92b488c-c704-11de-bb6f-00144feab49a.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/a92b488c-c704-11de-bb6f-00144feab49a.htmlJeffrey Kindler, chief executive of Pfizer, expressed confidence that US healthcare reform would be approved by the end of this year, and praised the Senate finance committee's latest draft in spite of the extra costs it would impose on his businessSun, 1 Nov 2009 17:58:00 +0000http://traxfer.ft.com/cms/s/0/e23cc0ac-c573-11de-8193-00144feab49a.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/e23cc0ac-c573-11de-8193-00144feab49a.htmlFalling sales of its now off-patent drug Adderall XR continue to weigh on the speciality pharmaceutical group, although strong growth in sales of new drugs are poised to compensateFri, 30 Oct 2009 20:46:02 +0000http://traxfer.ft.com/cms/s/3/73f5a600-c46e-11de-912e-00144feab49a.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/3/73f5a600-c46e-11de-912e-00144feab49a.htmlBosses of most drug companies must wish they had the Danish drugmaker's problems. What is the secret of its success?Thu, 29 Oct 2009 22:22:24 +0000http://traxfer.ft.com/cms/s/0/512a0bac-c4af-11de-8d54-00144feab49a.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/512a0bac-c4af-11de-8d54-00144feab49a.htmlAstraZeneca is poised to pay more than $500m to settle allegations in the US of marketing abuses of its second-most important drugThu, 29 Oct 2009 17:57:16 +0000http://traxfer.ft.com/cms/s/0/edc1bde2-c3fc-11de-8de6-00144feab49a.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/edc1bde2-c3fc-11de-8de6-00144feab49a.htmlThe group's traditional core market of prescription medicines in developed countries may fall to just a quarter of total sales according to Andrew Witty, chief executive of GSKWed, 28 Oct 2009 20:43:37 +0000http://traxfer.ft.com/cms/s/0/606d4184-c3b9-11de-a290-00144feab49a.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/606d4184-c3b9-11de-a290-00144feab49a.htmlStrong growth in emerging markets and Japan, and in consumer healthcare products, offset declines in US pharmaceuticals, but the drugs group expects strong sales of flu vaccineWed, 28 Oct 2009 13:28:26 +0000